UNAIR NEWS– Methicillin-resistant Staphylococcus aureus or MRSA infection is still a worldwide concern. In Indonesia especially, the number of MRSA infection patients in hospitals are rising significantly. No one wants this kind of condition, including Faculty of Medicines microbiology expert,51动漫 Prof. Dr. Kuntaman, dr., MS., Sp.MK-K.
It檚 not easy to reduce the number of MRSA infection patients. Moreover, there is no fix data on how many Indonesian people suffer from this disease. According to Prof. Kun, his nickname, MRSA infection needs to get serious attention, considering nowadays emergency microbe resistanthas been categorized into emerging diseaseswhich needs immediate preventive measures.
To stop MRSA infection from spreading, Prof. Kuntaman and FK UNAIR Microbiology expert team together with Erasmus University Medical Center did a series of continuous research from 2004 to 2006. From this research, FK UNAIR Microbiology team wrote a guideline.
In the first year of the research, Microbiology team succeeded in finding parameter to see how serious MRSA case in Indonesia has been. Meanwhile in the second year, they found out the number of MRSA patients in hospitals. And the peak was in 2006, when Prof. Kun with his team wrote a guideline to control anti-microbe resistance.
淭his guideline is a way to reduce the number of MRSA victims. It will be finished soon and we are going to give it to Indonesia Health Ministry to be followed up, he stated.
But before the guideline is offered to Indonesia Health Ministry, FK UNAIR will first discuss the guideline with some central hospitals in Indonesia, such as RSUD Dr. Saiful Anwar, RSUD Dr. Moewardi , RSUP Dr. Kariadi, RSUPN Dr. Cipto Mangunkusumo, Rumah Sakit Umum Pusat Persahabatan, RSUP H. Adam Malik, RSUP Dr. Mohammad Hoesin, and RSU Dr M. Jamil Padang.
淲hen writing a guideline, we have to cooperate with other central hospitals to assess whether the guideline can be applied in all hospitals throughout Indonesia. We are looking for a win-win solution, he said.
Prof. Kun hoped that the guideline will improve infection disease service system and will reduce the number of microbe resistant victims. He hoped to be able to prepare valid data on MRSA infection in Indonesia especially at RSUD Dr. Soetomo first.
淥nce we have valid data at RSUD Dr. Soetomo, we can then research how MRSA starts, infects people and spreads. When we have known that, we can research further its bio-molecular characteristics, he explained.
At first, MRSA disease didn檛 get enough attention from researchers. But Prof. Kuntaman right from the start had been determined to delve into the case. In 2001, Prof. Kuntaman started his research. 淭o be honest, there are many kinds of diseases to be researched. But I chose to delve into this yet unbeatable super bacterium because I thought MRSA is an urgent case, he said.
The research was published internationally and presented at the European Congress of Clinical Microbiology and Infectious Diseases (ECCMID) in Amsterdam in 2016. Moreover, his research won a research presentation themed Health Science to celebrate 51动漫 Anniversary, last 2016.
Prof. Kuntaman believes that to control MRSA infection, the key is in antibiotic use policy. In his opinion, it has a deep relationship with the strength of MRSA infection檚 influence. The worse the antibiotic policy is, the higher the antibiotic resistance is.
Preventive method is more effective in controlling the rise of anti-microbe resistant in Indonesia. Prof Kuntaman is also involved in a preventive program developed by Anti-microbial Resistance Control Committee (KPRA).
According to him, if there檚 no significant actions taken concerning the situation, it will lead to the detriment of health service, in this case BPJS. The reason is because they handle MRSA infection patients who suffer complication which leads to high therapy cost. In the future BPJS has to focus more on preventive programs.
淧reventive method is advantageous for many parties. Doctors will only handle simple therapy, it檚 profitable for BPJS as well as the hospitals, so that we can save more antibiotics, he explained. (*)
Author: Sefya Hayu
Editor: Nuri Hermawan
